Picture of Neurofibromatosis
Title: Picture of NeurofibromatosisCategory: ImagesCreated: 10/19/2009 4:29:00 PMLast Editorial Review: 6/22/2022 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - June 22, 2022 Category: Dermatology Source Type: news

Mesothelioma Clinical Trials Test Targeted Gene Therapy
For some patients, the future of mesothelioma cancer treatment may hinge on a pair of phase I clinical trials that opened earlier this year to study promising new drugs targeting specific genetic mutations. Precision medicine may finally be taking hold with malignant mesothelioma, clearing the path for significant, long-overdue advancements. The one-size-fits-all approach is fading. “There is some realistic hope now for patients,” Dr. Anthony Tolcher, co-founder of NEXT Oncology in San Antonio, told The Mesothelioma Center at Asbestos.com. “I am very optimistic. New avenues for treatment are opening up.” ...
Source: Asbestos and Mesothelioma News - June 21, 2022 Category: Environmental Health Authors: Fran Mannino Tags: Clinical Trials/Research/Emerging Treatments Source Type: news

How do people with neurofibromatosis type 1 (the forgotten victims) live? A grounded theory study - Foji S, Mohammadi E, Sanagoo A, Jouybari L.
BACKGROUND: Neurofibromatosis type I (NF1) is a rare genetic disorder, associated with some physical symptoms including spots and tiny bumps on the skin, and internal organ involvement. People suffering from neurofibromatosis face various challenges in the... (Source: SafetyLit)
Source: SafetyLit - January 27, 2022 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

What Are the Neurofibromatosis Types
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - November 19, 2021 Category: General Medicine Source Type: news

Longitudinal investigation of early motor development in neurofibromatosis type 1 - Pardej SK, Glad DM, Casnar CL, Janke KM, Klein-Tasman BP.
OBJECTIVE: Research indicates that children with neurofibromatosis type 1 (NF1) have weaknesses in fine and gross motor development in early childhood; however, little is known about the stability and developmental trajectory of motor functioning. We inves... (Source: SafetyLit)
Source: SafetyLit - October 23, 2021 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news

Novel Test Distinguishes Benign From Malignant Lesions in NF1 Novel Test Distinguishes Benign From Malignant Lesions in NF1
As well as distinguishing between benign precursor lesions and malignant peripheral nerve sheath tumors in patients with neurofibromatosis type 1, it can also be used to track response to treatment.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 6, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

In a common genetic disorder, blood test reveals when benign tumors turn cancerous
Neurofibromatosis type 1, or NF1, is the most common cancer predisposition syndrome, affecting 1 in 3,000 people worldwide. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - August 31, 2021 Category: American Health Source Type: news

Complications of neurofibromatosis 1 (NF1) in an adult with multiple comorbidities - Nnomadim OP, Bustamante Helfrich B.
Neurofibromatosis (NF) is an autosomal genetic disorder with three types, including NF1, NF2, and schwannomatosis. It is characterized by bulging and deforming masses arising from multiple nerves involving skin folds and connective tissues. Prompt diagnosi... (Source: SafetyLit)
Source: SafetyLit - August 27, 2021 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Diagnosing Neurofibromatosis 1, With and Without Genetic Testing Diagnosing Neurofibromatosis 1, With and Without Genetic Testing
For most children with NF1, the diagnosis can be made can using National Institutes of Health criteria published in 1988.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - July 27, 2021 Category: Dermatology Tags: Dermatology News Source Type: news

Antihypertension drug may help patients with noncancerous brain tumors affecting hearing
(Massachusetts General Hospital) New research led by investigators at Massachusetts General Hospital (MGH) and Massachusetts Eye and Ear indicates that the blood pressure drug losartan may benefit patients with neurofibromatosis type 2. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 15, 2021 Category: International Medicine & Public Health Source Type: news

Optic nerve firing may spark growth of vision-threatening childhood tumor
(NIH/National Institute of Neurological Disorders and Stroke) In a study of mice, researchers showed how the act of seeing light may trigger the formation of vision-harming tumors in young children who are born with neurofibromatosis type 1 (NF1) cancer predisposition syndrome. The research team, funded by the National Institutes of Health, focused on tumors that grow within the optic nerve, which relays visual signals from the eyes to brain. They discovered that the neural activity which underlies these signals can both ignite and feed the tumors. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 1, 2021 Category: Cancer & Oncology Source Type: news

Children's Tumor Foundation announces revised diagnostic criteria for NF1
(Children's Tumor Foundation) The Children's Tumor Foundation (CTF) today announced the publication of updated diagnostic criteria for the genetic disorder neurofibromatosis type 1 (NF1) in Genetics in Medicine, the official journal of the American College of Medical Genetics and Genomics. The new publication is the result of an extensive, multi-year collaborative effort of over 90 leading neurofibromatosis (NF) experts from around the globe, and is aimed at improving the accuracy and earlier diagnosis of NF1 in patients. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 19, 2021 Category: Biology Source Type: news

What Are Some Etiologies for Intellectual Disability?
Discussion “Intellectual disability (ID) is a neurodevelopmental disorder that is characterized by deficits in both intellectual functioning and adaptive function whose onset is in the development period.” Global developmental delay (GDD) is used to describe children from 0-5 years old with significant delays in 2 or more developmental areas. These delays may be transient but up to 2/3 of children with GDD will have ID. Overall 1-3% of the general population has ID which makes it very common. Most children with GDD/ID are identified because of delays in meeting milestones or general academic achievement. ID pat...
Source: PediatricEducation.org - May 3, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Risk factors for bullying victimization in children with neurofibromatosis type 1 (NF1) - Stavinoha PL, Solesbee C, Swearer SM, Svoboda S, Klesse LJ, Holland AA.
Neurofibromatosis type 1 (NF1) is an autosomal disorder associated with numerous physical stigmata. Children with NF1 are at known risk for attention-deficit/hyperactivity disorder (ADHD), academic struggles, and significant social difficulties and adverse... (Source: SafetyLit)
Source: SafetyLit - March 12, 2021 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

NIH Director Francis Collins Is Fighting This Coronavirus While Preparing for the Next One
In May 2020, Dr. Francis Collins, the longtime head of the National Institutes of Health (NIH), was called to the White House to meet with Jared Kushner, the then President’s son-in-law and adviser, and Dr. Deborah Birx, the head of the White House Coronavirus Task Force. A few weeks earlier, Congress had given the NIH $1.5 billion to try to speed up the process of developing new diagnostic tests for COVID-19, and the White House, which was dubious about increasing the rate of testing, wanted to know more about what the NIH was doing. Collins is technically the boss of Dr. Anthony Fauci, but during the pandemic he ha...
Source: TIME: Health - February 4, 2021 Category: Consumer Health News Authors: Belinda Luscombe Tags: Uncategorized COVID-19 feature Magazine Source Type: news